Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shot up 1.4% during trading on Wednesday. The stock traded as high as $47.75 and last traded at $47.75. Approximately 101 shares were traded during mid-day trading, a decline of 91% from the average session volume of 1,176 shares. The stock had previously closed at $47.0850.
Hikma Pharmaceuticals Price Performance
The business’s fifty day moving average is $43.43 and its two-hundred day moving average is $40.71.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals plc is a multinational pharmaceutical company that develops, manufactures and markets a broad range of medicines. Its portfolio includes generic, branded and specialty pharmaceutical products, as well as injectable medicines used in hospitals and other healthcare settings.
The company serves healthcare providers, pharmacies and patients across the United States, Europe, the Middle East and North Africa, and other international markets. Its products cover a variety of therapeutic areas, with operations spanning prescription medicines, hospital injectables and established branded treatments.
Hikma was founded in Jordan in 1978 by Samih Darwazah and has expanded into a global pharmaceutical business through organic growth and acquisitions.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
